Literature DB >> 24940945

Chemokine 'grooming' by cLECs directs DC migration.

Matthew C Woodruff1, Shannon J Turley2.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24940945     DOI: 10.1038/ni.2926

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  14 in total

Review 1.  Homing and cellular traffic in lymph nodes.

Authors:  Ulrich H von Andrian; Thorsten R Mempel
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

2.  CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions.

Authors:  Lars Ohl; Mariette Mohaupt; Niklas Czeloth; Gabriele Hintzen; Ziba Kiafard; Jörg Zwirner; Thomas Blankenstein; Golo Henning; Reinhold Förster
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

3.  Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells.

Authors:  Tri Giang Phan; Irina Grigorova; Takaharu Okada; Jason G Cyster
Journal:  Nat Immunol       Date:  2007-07-29       Impact factor: 25.606

4.  Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration.

Authors:  Asolina Braun; Tim Worbs; G Leandros Moschovakis; Stephan Halle; Katharina Hoffmann; Jasmin Bölter; Anika Münk; Reinhold Förster
Journal:  Nat Immunol       Date:  2011-08-14       Impact factor: 25.606

5.  B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity.

Authors:  E Ashley Moseman; Matteo Iannacone; Lidia Bosurgi; Elena Tonti; Nicolas Chevrier; Alexei Tumanov; Yang-Xin Fu; Nir Hacohen; Ulrich H von Andrian
Journal:  Immunity       Date:  2012-03-01       Impact factor: 31.745

6.  Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions.

Authors:  Anne L Fletcher; Veronika Lukacs-Kornek; Erika D Reynoso; Sophie E Pinner; Angelique Bellemare-Pelletier; Mark S Curry; Ai-Ris Collier; Richard L Boyd; Shannon J Turley
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

7.  CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation.

Authors:  Joanna R Groom; Jillian Richmond; Thomas T Murooka; Elizabeth W Sorensen; Jung Hwan Sung; Katherine Bankert; Ulrich H von Andrian; James J Moon; Thorsten R Mempel; Andrew D Luster
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

8.  The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes.

Authors:  Maria H Ulvmar; Kathrin Werth; Asolina Braun; Poonam Kelay; Elin Hub; Kathrin Eller; Li Chan; Beth Lucas; Igor Novitzky-Basso; Kyoko Nakamura; Thomas Rülicke; Robert J B Nibbs; Tim Worbs; Reinhold Förster; Antal Rot
Journal:  Nat Immunol       Date:  2014-05-11       Impact factor: 25.606

9.  Structure-based programming of lymph-node targeting in molecular vaccines.

Authors:  Haipeng Liu; Kelly D Moynihan; Yiran Zheng; Gregory L Szeto; Adrienne V Li; Bonnie Huang; Debra S Van Egeren; Clara Park; Darrell J Irvine
Journal:  Nature       Date:  2014-02-16       Impact factor: 49.962

10.  Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2.

Authors:  Sophie E Acton; Jillian L Astarita; Deepali Malhotra; Veronika Lukacs-Kornek; Bettina Franz; Paul R Hess; Zoltan Jakus; Michael Kuligowski; Anne L Fletcher; Kutlu G Elpek; Angelique Bellemare-Pelletier; Lindsay Sceats; Erika D Reynoso; Santiago F Gonzalez; Daniel B Graham; Jonathan Chang; Anneli Peters; Matthew Woodruff; Young-A Kim; Wojciech Swat; Takashi Morita; Vijay Kuchroo; Michael C Carroll; Mark L Kahn; Kai W Wucherpfennig; Shannon J Turley
Journal:  Immunity       Date:  2012-08-09       Impact factor: 31.745

View more
  1 in total

Review 1.  Cellular and molecular regulation of innate inflammatory responses.

Authors:  Juan Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2016-10-31       Impact factor: 11.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.